Maxim Group analyst Matthew Galinko still thinks Strategy is a buy. He just thinks it’s a slightly less expensive buy than he did before.
The firm cut its 12-month price target on MSTR from $250 to $215 while reaffirming its Buy rating. With shares trading around $97, that revised target still implies roughly 120% upside. In other words, Galinko lopped off $35 and the stock would still need to more than double to hit his number.
What’s behind the trim
The adjustment reflects a familiar cocktail of factors: persistent stock volatility, fluctuating Bitcoin prices, and the general uncertainty that comes with a company whose share price is essentially a leveraged bet on a single asset. Strategy’s stock doesn’t just correlate with Bitcoin. It amplifies it, in both directions.
Maxim Group reiterated its confidence in both Strategy’s ongoing Bitcoin accumulation strategy and its legacy analytical software business as drivers of long-term value.
